GlycoEra AG
UNVERIFIED COMPANY
About
Services
Reviews
You are in a "view as others" mode
Overview
Advancing Glycan Mediated Therapy
Description
GlycoEra is positioned as the leading precision protein degradation company. Bifunctional biologics (G-LyTACs), designed by our novel and proprietary technology bind to disease-causing proteins and transport them to the lysosome using naturally occurring endocytic receptors. The disease-causing proteins are degraded in the lysosome and removed from the body. Unlike intracellular protein degraders, like PROTACs and molecular glues, our technology can access targets that are extracellular and membrane proteins, thereby opening up novel targets and therapeutic areas for intervention.
Founded 2020
20-30
Categories
Products
Looks like GlycoEra AG has no published products yet.
Services
Looks like GlycoEra AG has no published services yet.
Company reviews
Profile Strength:
undefined%
profile
completion